M3 Valuation
| MTHRY Stock | USD 6.19 0.24 4.03% |
At this time, the entity appears to be undervalued. M3 Inc owns a latest Real Value of $6.53 per share. The recent price of the entity is $6.19. Our model forecasts the value of M3 Inc from analyzing the entity fundamentals such as Return On Asset of 0.13, price to book of 9.69 X, and Profit Margin of 0.20 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that M3's price fluctuation is somewhat reliable at this time. Calculation of the real value of M3 Inc is based on 3 months time horizon. Increasing M3's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since M3 is currently traded on the exchange, buyers and sellers on that exchange determine the market value of M3 Pink Sheet. However, M3's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.19 | Real 6.53 | Hype 5.97 | Naive 6.71 |
The intrinsic value of M3's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence M3's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of M3 Inc helps investors to forecast how M3 pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of M3 more accurately as focusing exclusively on M3's fundamentals will not take into account other important factors: M3 Total Value Analysis
M3 Inc is now projected to have takeover price of 19.27 B with market capitalization of 18.11 B, debt of , and cash on hands of 129.66 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the M3 fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
19.27 B | 18.11 B | 129.66 B |
M3 Investor Information
The company last dividend was issued on the 29th of March 2022. Based on the key measurements obtained from M3's financial statements, M3 Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.M3 Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. M3 has an asset utilization ratio of 60.16 percent. This suggests that the Company is making $0.6 for each dollar of assets. An increasing asset utilization means that M3 Inc is more efficient with each dollar of assets it utilizes for everyday operations.M3 Ownership Allocation
M3 Inc secures a total of 1.36 Billion outstanding shares. Around 99.99 % of M3 outstanding shares are held by general public with 0.007 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.M3 Profitability Analysis
The company reported the revenue of 208.16 B. Net Income was 63.84 B with profit before overhead, payroll, taxes, and interest of 123.27 B.About M3 Valuation
Our relative valuation model uses a comparative analysis of M3. We calculate exposure to M3's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of M3's related companies.M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan. M3 operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 9384 people.
8 Steps to conduct M3's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates M3's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct M3's valuation analysis, follow these 8 steps:- Gather financial information: Obtain M3's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine M3's revenue streams: Identify M3's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research M3's industry and market trends, including the size of the market, growth rate, and competition.
- Establish M3's growth potential: Evaluate M3's management, business model, and growth potential.
- Determine M3's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate M3's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
M3 Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 678.9 M | |
| Quarterly Earnings Growth Y O Y | -0.011 | |
| Forward Price Earnings | 42.1941 | |
| Retained Earnings | 192.9 B |
Additional Tools for M3 Pink Sheet Analysis
When running M3's price analysis, check to measure M3's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy M3 is operating at the current time. Most of M3's value examination focuses on studying past and present price action to predict the probability of M3's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move M3's price. Additionally, you may evaluate how the addition of M3 to your portfolios can decrease your overall portfolio volatility.